Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol.
Ynke LarivièreTrésor ZolaElke StoppieVivi MaketaJunior MatangilaPatrick MitashiJessie De BieHypolite Muhindo-MavokoJean-Pierre Van GeertruydenPierre Van DammePublished in: BMJ open (2021)
NCT04186000; Pre-results.